Is Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $50 To Buy? [Yahoo! Finance]
Roivant Sciences Ltd. (ROIV)
Company Research
Source: Yahoo! Finance
The close of 2024's third quarter is seeing Wall Street rejoice as the Federal Reserve finally delivers its highly awaited interest rate cut. The central bank decided to cut rates by 50 basis points, and while the immediate aftermath saw stocks close lower, the next day was the complete opposite. On the day after the interest rate cut, markets soared as investors digested the latest data set. It saw the benchmark S&P index soar to a record close as it gained 1.70% and ended the day's trading at 5,713 points. This wasn't the only record set during the day, with the Dow blue chip stock index jumping by 1.26%. In terms of gains though, both of these were surpassed by the broader NASDAQ index which jumped by 2.61% during the day's trading. While some of these gains are naturally because of investors cheering an interest rate cut, there might be other factors at play here too. For instance, fund ClearBridge Investments head of economic and marketing strategy Jeff Schulze shared that “
Show less
Read more
Impact Snapshot
Event Time:
ROIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ROIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ROIV alerts
High impacting Roivant Sciences Ltd. news events
Weekly update
A roundup of the hottest topics
ROIV
News
- U.S. can become a crypto superpower with 'sensible' regulation, Eric Trump says [MSNBC.com]MSNBC.com
- U.S. can become a crypto superpower with ‘sensible' regulation, Eric Trump says [CNBC]CNBC
- Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary SarcoidosisGlobeNewswire
- Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary SarcoidosisGlobeNewswire
- Everything to know about Vivek Ramaswamy, co-lead of the Department of Government Efficiency with Elon Musk [Business Insider]Business Insider
ROIV
Earnings
- 11/12/24 - Miss
ROIV
Analyst Actions
- 11/13/24 - HC Wainwright
ROIV
Sec Filings
- 12/20/24 - Form 4
- 12/20/24 - Form 144
- 12/18/24 - Form 144
- ROIV's page on the SEC website